American Record Holder Gwen Berry Breaks Doping Rule, Loses Record
American Record Holder Gwen Berry Breaks Doping Rule, Loses Record
USADA announced today that Gwen Berry declared an inhaler that contained an illegal substance at the U.S. indoor championships in March. Berry broke the Ame
USADA announced today that Gwen Berry declared an inhaler that contained an illegal substance at the U.S. indoor championships in March. Berry broke the American record in the hammer in May and won the weight throw at U.S. indoors. The USADA sanction includes a loss of her American hammer record.
The sanction is ultimately a slap on the wrist for sloppy paperwork. USADA said in the announcement of Berry's test that:
"Berry, 26, declared the use of an inhaler containing the prohibited substance Vilanterol Trifenatate, during an in-competition sample collection at the United States Track & Field (“USATF”) Indoor Track & Field Championships in Portland, Oregon. The results of that in-competition test were negative. Vilanterol Trifenatate is a Beta-2 Agonist, prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing (the “Protocol”) and the International Association of Athletics Federations (“IAAF”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency (“WADA”) Prohibited List. After a thorough review of the case, including Berry’s medical records, USADA has accepted her explanation that the Vilanterol Trifenatate, was not being used in an effort to enhance her performance and that she was taking the prescribed medication in a therapeutic dose under the care of a physician."
In other words: Berry didn't even test positive, but she admitted in her paperwork that she was taking a banned substance.
Her suspension will end one day before the Olympic Trials.
The sanction is ultimately a slap on the wrist for sloppy paperwork. USADA said in the announcement of Berry's test that:
"Berry, 26, declared the use of an inhaler containing the prohibited substance Vilanterol Trifenatate, during an in-competition sample collection at the United States Track & Field (“USATF”) Indoor Track & Field Championships in Portland, Oregon. The results of that in-competition test were negative. Vilanterol Trifenatate is a Beta-2 Agonist, prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing (the “Protocol”) and the International Association of Athletics Federations (“IAAF”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency (“WADA”) Prohibited List. After a thorough review of the case, including Berry’s medical records, USADA has accepted her explanation that the Vilanterol Trifenatate, was not being used in an effort to enhance her performance and that she was taking the prescribed medication in a therapeutic dose under the care of a physician."
In other words: Berry didn't even test positive, but she admitted in her paperwork that she was taking a banned substance.
Her suspension will end one day before the Olympic Trials.
Related Content
- Replay: Continental Tour: Huelva | Apr 30 @ 4 PM
Apr 30, 2024
- Craziest Penn Relays Ever?! Plus, An Interview With Liam Murphy | The FloTrack Podcast (Ep. 664)
Apr 30, 2024
- Vashti Cunningham Wins Olympic Development High Jump at Penn Relays
Apr 29, 2024
- Yared Nuguse Sets Penn Relays Record in Olympic Development Mile
Apr 29, 2024
- Spain Women Win Olympic Development 4x100m at Penn Relays
Apr 29, 2024
- Karayme Bartley Jamaica Wins 400m Olympic Development Race
Apr 29, 2024
- Akani Simbine Produces 100m Stunner At Diamond League Shanghai/Suzhou
Apr 29, 2024
- Leah Anderson Wins Olympic Development Womens 400m at Penn Relays
Apr 29, 2024
- Sage Hurta Klecker Wins Olympic Development 1500m Penn Relays
Apr 29, 2024